ReviewWorld journal of gastroenterology2014
Colorectal cancer surveillance: what's new and what's next.
Review in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Surgery along the embryological planes for colon cancer: a systematic review of complete mesocolic excision.International journal of colorectal disease · 2016Pooled it
- Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.The American journal of gastroenterology · 2016Guideline
- American Cancer Society Colorectal Cancer Survivorship Care Guidelines.CA: a cancer journal for cliniciansGuideline
- Cost-Effectiveness of Surveillance after Metastasectomy of Stage IV Colorectal Cancer.Cancers · 2023Article
- Article
- Assessing surveillance utilization and value in commercially insured patients with colorectal cancer.The American journal of managed care · 2022Article
- Dose Reduction and Diagnostic Performance of Tin Filter-Based Spectral Shaping CT in Patients with Colorectal Cancer.Tomography (Ann Arbor, Mich.) · 2022Article
- Circulating plasma microRNAs in colorectal neoplasia: A pilot study in assessing response to therapy.Translational oncology · 2021Article
- KRAS mutations by digital PCR in circulating tumor cells isolated from the mesenteric vein are associated with residual disease and overall survival in resected colorectal cancer patients.International journal of colorectal disease · 2020Article
- Abnormal expression of ABCD3 is an independent prognostic factor for colorectal cancer.Oncology letters · 2020Article
- Observational
- Emergency resection surgery for colorectal cancer: Patterns of recurrent disease and survival.World journal of gastrointestinal pathophysiology · 2018Article
- Preoperative PET/CTContrast media & molecular imaging · 2018Article
- Surveillance after curative treatment for colorectal cancer.Nature reviews. Clinical oncology · 2017Review
- Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations.Clinical Medicine Insights. Oncology · 2017Review
- Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances.World journal of gastroenterology · 2016Review
- Optimal delivery of colorectal cancer follow-up care: improving patient outcomes.Patient related outcome measures · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The accumulated evidence from two decades of randomized controlled trials has not yet resolved the question of how best to monitor colorectal cancer (CRC) survivors for early detection of recurrent and metachronous disease or even whether doing so has its intended effect. A new wave of trial data in the coming years and an evolving knowledge of relevant biomarkers may bring us closer to understanding what surveillance strategies are most effective for a given subset of patients. To best apply these insights, a number of important research questions need to be addressed, and new decision making tools must be developed. In this review, we summarize available randomized controlled trial evidence comparing alternative surveillance testing strategies, describe ongoing trials in the area, and compare professional society recommendations for surveillance. In addition, we discuss innovations relevant to CRC surveillance and outline a research agenda which will inform a more risk-stratified and personalized approach to follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.